Karyopharm Therapeutics Inc. (KPTI) Financials

KPTI Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 131.4 million 397.1 million
Dec. 31, 2025 108.4 million 401.3 million
Sept. 30, 2025 96.2 million 365.5 million
June 30, 2025 104.9 million 343.8 million

KPTI Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 -22.7 million 3.0 million
Dec. 31, 2025 -11.8 million 3.9 million
Sept. 30, 2025 -5.9 million 2.8 million
June 30, 2025 -18.7 million 3.8 million

KPTI Net Income

No data available :(

KPTI Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 90.9 million 192.2 million 5.5 million
Dec. 31, 2025 63.7 million 205.9 million 6.7 million
Sept. 30, 2025 45.9 million 176.7 million 6.9 million
June 30, 2025 51.7 million 152.3 million 7.6 million

KPTI Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 24.7 million
Dec. 31, 2025 18.0 million
Sept. 30, 2025 8.7 million
June 30, 2025 8.6 million

KPTI Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 - 33.8 million 26.7 million -
Dec. 31, 2025 - 27.7 million 22.8 million -
Sept. 30, 2025 - 30.5 million 26.6 million -
June 30, 2025 - 32.8 million 28.5 million -

KPTI Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 35.1 million 1.4 million
Dec. 31, 2025 34.1 million 1.5 million
Sept. 30, 2025 44.0 million 2.1 million
June 30, 2025 37.9 million 1.1 million

KPTI Revenue by Segment
Graph available only for paid members. Upgrade to see it.

KPTI

Price: $9.11

52 week price:
3.65
10.99

Earnings Per Share: -17.52 USD

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 1.7 million

Ebitda: -30.9 million

Market Capitalization: 205.6 million

Links: